Vertex Pharmaceuticals (VRTX) Earnings (2009 - 2026)
Vertex Pharmaceuticals (VRTX) earnings from Mar 31, 2009 to Mar 31, 2026. The TTM Vertex Pharmaceuticals (VRTX) earnings is $4.34B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Vertex Pharmaceuticals (VRTX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +10.00% |
| 5 Years TTM | +9.45% |
Annual Earnings change of Vertex Pharmaceuticals (VRTX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $1.03B | -73.91% |
| 2025 | $3.95B | -838.09% |
| 2024 | -$536M | -114.80% |
| 2023 | $3.62B | +8.96% |
| 2022 | $3.32B | +41.84% |
| 2021 | $2.34B | -13.63% |
| 2020 | $2.71B | +130.43% |
| 2019 | $1.18B | -43.88% |
| 2018 | $2.10B | +695.85% |
| 2017 | $263M | -335.15% |
| 2016 | -$112M | -79.86% |
| 2015 | -$556M | -24.67% |
| 2014 | -$739M | +65.96% |
| 2013 | -$445M | +315.80% |
| 2012 | -$107M | -461.95% |
| 2011 | $30M | -103.92% |
| 2010 | -$755M | +17.51% |
| 2009 | -$642M | +39.65% |
| 2008 | -$460M | N/A |
Comparison Vertex Pharmaceuticals (VRTX) five years earnings CAGR with competitors
Vertex Pharmaceuticals (VRTX) five years earnings CAGR is 9.45%.